₹42.05
Score
28
Technically Bearish
Advice
Marksans Pharma Share Price - 1 Year Trend
Marksans Pharma Price Change Analysis
Marksans Pharma Key Statistics
-
P/E Ratio
16.5
-
PEG Ratio
-0.4
-
Market Cap Cr
1721.2
-
Price to Book Ratio
19.2
-
EPS
2.5
-
Dividend
25 ()
-
Relative Strength Index
39.93
-
Money Flow Index
43.28
-
MACD Signal
-1.79
-
Average True Range
1.92
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
Marksans Pharma Synopsis
NSE-Medical-Diversified
Marksans Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 599.55 Cr. and Equity Capital is Rs. 40.93 Cr. for the Year ended 31/03/2021. Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364.-
Market Cap
1,721.17
-
Sales
658.29
-
Shares in Float
-
No of Funds
54
-
Yield
0.6
-
Book Value
2.18
-
U/D Vol Ratio
0.5
-
LTDebt/Equity
-
Alpha
-0.27
-
Beta
1.28
Marksans Pharma Ownership
| Owner Name | Jun-21 |
|---|---|
| Promoters | 48.25% |
| Mutual Funds | 0.34% |
| Foreign Portfolio Investors | 2.55% |
| Financial Institutions/ Banks | 0% |
| Individual Investors | 41.71% |
| Others | 7.15% |
Marksans Pharma Management
| Name | Designation |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
| Mr. Varddhman V Jain | Whole Time Director |
| Mr. Abhinna Sundar Mohanty | Independent Director |
| Mr. Digant Mahesh Parikh | Independent Director |
| Mr. Seetharama R Buddharaju | Independent Director |
| Dr.(Mrs.) Meena Rani Surana | Independent Director |
Marksans Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Eps And Sales Estimates
Marksans Pharma Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
Marksans Pharma Technicals
EMA & SMA
CURRENT PRICE
EMA
Marksans Pharma Resistance and Support
Marksans Pharma Delivery and Volume
Marksans Pharma Price Change Analysis
Corporate Action
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|
Videos
About Company
News
FAQs
Marksans Pharma share price is ₹42 As on 28 June, 2022 | 00:02
The Market Cap of Marksans Pharma is ₹1721.2 As on 28 June, 2022 | 00:02
The P/E ratio of Marksans Pharma is 9.2 As on 28 June, 2022 | 00:02
The PB ratio of Marksans Pharma is 1.4 As on 28 June, 2022 | 00:02
The 52 week High & Low of Marksans Pharma is ₹93.6/₹38.6 respectively As on 28 June, 2022 | 00:02